About us
The Company.
Meabco is a Biotech Company primarily focused on oncology and radiation protection.
The company was established in 2000, and its head office is located in Copenhagen, Denmark
|
Products
BP-Cx-1 - Meabco’s product portfolio is based on the combination of BP-Cx-1 and metal ions of known therapeutic potential. BP-Cx-1, a globular polydentant ligand, is a refined natural substance, based on acid polymers of the benzo-poly-carbonic family. BP-Cx-1 is capable of chelating/encapsulating the metal ions, and facilitates their uptake into cells.
BP-C1 - BP-C1 is based on a combination of BP-Cx-1 and platinum. It contains approximately 100 times less platinum than ordinary doses of Cisplatin used in chemotherapeutical drugs, resulting in a much enhanced safety profile. At the same time, clinical efficacy is maintained or improved due to the carrier effect of the polymer.
BP-C2 - The company’s second product is BP-C2, which is based on BP-Cx-1 combined with molybdenum salts. BP-C2 is in preclinical development for prevention of side effects arising from cancer radiotherapy, nuclear radiation and irradiation at large. |